- STUDY PROTOCOL
- Open Access
- Open Peer Review
The RHESA-CARE study: an extended baseline survey of the regional myocardial infarction registry of Saxony-Anhalt (RHESA) design and objectives
BMC Cardiovascular Disorders volume 16, Article number: 159 (2016)
Cardiovascular disease (CVD) is a leading cause of death in Europe. In Germany, a declining mortality rate from acute myocardial infarction (AMI) has been observed in the last decades. Nevertheless, there are large differences between the federal states when looking at the mortality and morbidity of AMI. Saxony-Anhalt is one of the federal states with the highest mortality rates for AMI in Germany. In 2012, the regional myocardial infarction registry of Saxony-Anhalt (RHESA) was established to investigate the individual, infrastructural, and health care factors with respect to an urban (city of Halle) and rural (region of Altmark) population. For detailed observation the RHESA-CARE study was conducted in 2014. RHESA-CARE focuses on the symptoms during infarction, the behaviour of patients while alerting for infarction, the use of rehabilitation possibilities, and long-term care.
RHESA-CARE is an extended baseline survey of AMI patients registered in RHESA who are aged 25 or more, and inhabitants of the city of Halle (Saale) or the district of Altmark in the federal state of Saxony-Anhalt, Germany. Detailed information was collected on classical and psychosocial cardiovascular risk factors as well as factors of alerting behaviour, first aid, and utilization of medical and rehabilitation services. High data quality is ensured by a detailed system of quality control.
RHESA-CARE has the main objective to investigate factors that influence morbidity and mortality rates due to AMI. Another purpose is the comparison of a rural and urban patient population. It provides an opportunity to serve as a base for improvement of patients’ behaviour and health care as well as further research.
Worldwide, cardiovascular disease (CVD) is a public health problem contributing to 30 % of global mortality (15,616.1 million deaths) and 10 % of the global disease burden [1, 2]. CVD remains also the leading cause of death among Europeans. Over a third of deaths from CVD in the EU are from coronary heart disease (CHD) . One of the five main manifestations of CHD is acute myocardial infarction (AMI). Since 1980 in Germany, the mortality rates of AMI have been declining . However, looking at the occurrence of AMI there are large differences between the federal states of Germany regarding the mortality and morbidity. While in 2012 the age-standardized mortality rate for AMI in Germany was 46 deaths per 100,000 inhabitants, Saxony-Anhalt, a federal state in the eastern part of Germany, has a mortality rate of 67 per 100,000 inhabitants (age-adjusted). However, for Bavaria, a federal state in the southern part of Germany, 47 deaths by AMI per 100,000 inhabitants (age-adjusted) was observed . Saxony-Anhalt is one of the federal states with the highest mortality rates for AMI in Germany. The reasons are still unclear and speculative. Different factors were discussed which could be divided into two fields.
First, individual factors:
less use of medical services (ambulant as well as post-hospital) ,
adherence to medication .
Second, structural factors:
lower doctor density (family doctor and cardiologist),
low number of first aiders in the population ,
insufficient access to rehabilitation units,
insufficient access to heart training groups, and
not satisfying guideline medication .
To answer the question of which factors influence the mortality rate in Saxony-Anhalt, the regional myocardial infarction registry of Saxony-Anhalt (RHESA) was established in 2012. It investigated some of the factors mentioned above and is described elsewhere . RHESA focuses on the comparison of an urban (city of Halle) and rural (region of Altmark) region. Data collected in RHESA enabled us to assess different levels of quality of health care of patients with AMI (structural, process, and outcome) in these areas. In the registry, we were not able to survey all individual and structural factors mentioned above. Therefore, we conducted an extended baseline survey in 2014. This extension, namely RHESA-CARE, focuses on the symptoms during infarction, the behaviour of patients while alerting for infarction, the use of rehabilitation facilities (multidisciplinary rehabilitation programs, and heart training groups), and long-term care. Furthermore, we plan a follow-up of the MI patients after 2 years of baseline. Here we will examine the occurrence of major adverse cardiac events (MACE) as well as changes in individual cardiovascular risk factors. This paper presents the design and objectives of RHESA-CARE.
The aims of RHESA-CARE are:
profile the individual factors of AMI patients (Table 1) at baseline and 2 years of follow-up,
detect differences in these risk factors between the rural and urban populations of Saxony-Anhalt,
elucidate reasons for regional variations in structural factors, e.g. availability of a cardiologist, family doctors, and heart training groups,
examine the influence of individual and structural risk factors and determents like guideline care, heart training groups, and disease management programs on the occurrence of major adverse cardiac events (MACE),
examine the change in risk profile between baseline and follow-up, and
quantify the influence of determents on changes in risk profile.
RHESA-CARE is a extended baseline survey with a planned 2 years follow-up of AMI patients registered in RHESA. RHESA-CARE has been conducted since May 2014 at the Institute of Medical Epidemiology, Biostatistics, and Informatics (IMEBI). It is being funded by the Wilhelm Roux Program of the Faculty of Medicine of the Martin Luther University Halle-Wittenberg.
RHESA includes patients with AMI aged 25 years or more. They have to be inhabitants of the city of Halle (Saale) or of the rural district Altmark in the federal state Saxony-Anhalt, Germany . RHESA-CARE comprises all patients from RHESA who have survived AMI and agree with the survey (N = 600 per year). All inclusion criteria are shown in Table 2.
We include all surviving AMI patients occurring after April 2014. For RHESA-CARE we expect a response of 80 % from all eligible patients. We had to exclude patients who were not capable of completing the interview in German.
Recruitment of patients and data collection
The recruitment includes at least two written invitations and active contact attempts by the study personnel via telephone if the patient does not respond to the written invitations (Fig. 1). Six weeks after discharge from hospital, we contact the patients with a covering letter and a patient information flyer about RHESA-CARE by mail (first contact phase). Patients with a known telephone number are identified and were contacted four working days after the postal contact by telephone. The first contact phase contains 10 phone calls at different times and days. If no contact can be made over at least two weeks, a reminder invitation is mailed to the subject (second contact phase). This phase corresponds to the first phase: covering letter and telephone contact. For those patients without a registered telephone number, two invitation letters with reply-paid envelope are sent. If the patient agrees to the survey, a computer assisted telephone interview (CATI) is fixed, and we submit a confirmation of appointment with additional information. We inform the patients to prepare a list of medication before and after the AMI and hold the address of the family doctor. Responders, who are not able to conduct the CATI (deafness, lack of concentration, or physical disability) obtain a postal self-administered questionnaire. This questionnaire includes the same items as the CATI.
If we were not able to reach the patient we checked address by the respective registry office. Should the address changed, we start the first contact phase again. When it was impossible to reach the patient or the patient does not agree to take part in our study we send them a self-administered non-responder questionnaire.
After the implementation of the CATI, or the self-administered questionnaire, we send a self-administered questionnaire to the family doctor, with a request to answer it, and return copies of the discharge summary from the hospital and rehabilitation unit.
After selection of interview items, a pilot study was performed to test the instruments and logistics of data collection. Slight modifications were made before the main phase of RHESA-CARE started in January 2015. The CATI includes classical and psychosocial cardiovascular risk factors as well as factors of alerting behaviour, first aid, and utilization of medical and rehabilitation services. We use highly standardized and validated instruments of data collection which have been applied in several completed or ongoing studies to ensure qualitiy of data and comparability. Questionnaire items were selected and adapted from:
CARLA study (CARdiovascular disease, Living and Ageing in Halle) ,
DIOS study (Diagnosis Optimisation Study) , and
IRENA (evaluation of the Intensified Rehabilitation Aftercare Program) .
For some special items we developed questions. Details on the sources of the questionnaire modules are listed in Table 3.
We used a non-responder questionnaire to identify possible structural differences between responder and non-responder. This questionnaire is a short version of the responder questionnaire and contains 15 items for cardiovascular disease, rehabilitation, body mass index (BMI), health condition, need for care, and social status. Furthermore, we prepared a questionnaire for the family doctor (FDQ). The FDQ contains the items: blood values, blood pressure, medication before/after AMI, and German disease management program (DMP) .
The study was designed to fulfil the recommendations of the German Good Epidemiologic Practices . We include several procedures for quality assurance. Before the main study started, the standard operating procedures (SOPs) were written and a pilot study was conducted. The aim of the pilot study was to test the time plan and the questionnaires.
After an initial interviewer training course, interviewers were monitored regularly. In addition, we have regular discussions with the interviewers to resolve questions.
The recruitment progress, given as the number of registered patients, is monitored monthly.
A plausibility control of the interview data is done monthly and is the basis for regular discussions with the interviewers.
The self-administered questionnaires are edited visually by the study personnel before the data are entered into the database. Self-administered questionnaires with incomplete information or missing data are marked and questions are prepared for requesting by telephone.
The FDQ is used to compare the doctors information with that of the patient as well as to complete the data of the patient if necessary.
In the baseline survey we are focused on explorative analysis. Therefore, we plan a descriptive analysis of individual and structural factors. To give an overview of possible differences in urban and rural patients, for example the behaviour of alerting, participation in cardiovascular rehabilitation, and utilization of medical services, we will perform stratified analysis. Furthermore, we focus on gender differences in factors like symptoms of MI, depression, and participation in cardiovascular rehabilitation. To examine the influence of risk factors and structural factors on the occurrence of MACE, we use multiple Cox-regression. For analysis of changing in risk profile we use descriptive statistics. We use SAS®;, Version 9.4 (SAS Institutes, Cary, NC), as well as R®;(Version 3.0.3) for the analysis.
Saxony-Anhalt is one of the federal states of Germany with the highest AMI mortality and morbidity rates. The causes are unclear and need to be surveyed. In previous studies, different factors at an individual patient level were discussed, as well as structural conditions and the quality of process factors.
RHESA-CARE is an extended baseline survey with the aim of a follow-up after 2 years. The main objective of RHESA-CARE is to investigate factors that influence morbidity and mortality rates due to AMI. Another purpose is the comparison of a rural and urban AMI patient population. Because of the selection of standardized interview items applied in other regional studies with the data of RHESA-CARE, a comparison with other registers like MONICA/KORA is possible.
Both RHESA and RHESA-CARE enable us to assess different levels of quality of health care of patients with AMI (structural, process and outcome). In particular, the comparison of rural and urban differences of structural effects and lifestyle components could be described.
The study serves as a base for improvement of patients’ behaviour and health care as well as further research of the named risk factors.
AMI, acute myocardial infarction; BMI, body mass index; CARLA, CARdiovascular disease, living and ageing in Halle; CATI, computer assisted telephone interview; MONICA/KORA, myocardial infarction registry of the cooperative health research in the region of Augsburg; CVD, cardiovascular disease; CHD, coronary heart disease; DMP, disease management programme; DIOS, diagnosis optimisation study; DMP, German disease management program; FDQ, family doctor questionnaire; GLC, guideline-care; IMEBI, institute of medical epidemiology, biostatistics, and informatics; IRENA, evaluation of the intensified rehabilitation aftercare program; KORA-DMP, KORA postal questionnaire wave in 2011; MACE, major adverse cardiac events; RHESA, regional myocardial infarction registry Saxony-Anhalt; RHESA-CARE, follow-up of RHESA; SOP, standard operating procedure
Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in europe: epidemiological update. Eur Heart J. 2013; 34(39):3028–34.
Mendis S, Thygesen K, Kuulasmaa K, Giampaoli S, Mähönen M, Ngu Blackett K, Lisheng L. World health organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol. 2011; 40(1):139–46.
Nichols M, Townsend N, Scarborough P, Leal J, Luengo-Fernandez R, Gray A, Rayner M. European Cardiovascular Disease Statistics 2012. Sophia Antipolis: European Heart Network and European Society of Cardiology, Brussels, European Society of Cardiology; 2012.
German Heart Foundation, (ed).Deutscher Herzbericht 2013. Frankfurt am Main; 2013.
German Heart Foundation, (ed).Deutscher Herzbericht 2014. Frankturt am Main; 2014.
Moebus S, Hanisch J, Bramlage P, Lösch C, Hauner H, Wasem J, Jöckel KH. Regional unterschiedliche prävalenz des metabolischen syndroms. Dtsch Arztebl. 2008; 105(12):207–13.
Stang A, Stang M. An inter-state comparison of cardiovascular risk factors in germany: towards an explanation of high ischemic heart disease mortality in saxony-anhalt. Deutsches Ärzteblatt Intl. 2014; 111(31-32):530–6.
Stansfeld SA, Marmot MG, (eds).Stress and the heart: psychosocial pathways to coronary heart disease. Williston: BMJ Books Stress and the heart: Psychosocial pathways to coronary heart disease; 2002.
Steptoe A, Kivimäki M. Stress and cardiovascular disease: an update on current knowledge. Annu Rev Public Health. 2013; 34:337–54.
Arbeitslosigkeit Im Zeitverlauf Dezember 2014. Bundesagentur für Arbeit.
Rattay P, Butschalowsky H, Rommel A, Prütz F, Jordan S, Nowossadeck E, Domanska O, Kamtsiuris P. Inanspruchnahme der ambulanten und stationären medizinischen versorgung in deutschland. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2013; 56(5-6):832–44.
Gao Y, Zhang H-j. The effect of symptoms on prehospital delay time in patients with acute myocardial infarction. J Int Med Res. 2013; 41(5):1724–31.
Gäartner C, Walz L, Bauernschmitt E, Ladwig KH. The causes of prehospital delay in myocardial infarction. DEUTSCHES ARZTEBLATT-KOLN-. 2008; 105(15):286–91.
Bosworth HB, Powers BJ, Oddone EZ. Patient self-management support: novel strategies in hypertension and heart disease. Cardiol Clin. 2010; 28(4):655–63.
Teich N, Engelmann L, Pfeiffer D. Laienreanimation: schlechte kenntnisse in Deutschland. DMW-Deutsche Medizinische Wochenschrift. 2005; 130(48):2759–62.
Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, et al. Esc guidelines for the management of acute myocardial infarction in patients presenting with st-segment elevation. Eur Heart J. 2012; 33(20):2569–619.
Stark R, Kirchberger I, Hunger M, Heier M, Leidl R, von Scheidt W, Meisinger C, Holle R. Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines. Clin Res Cardiol. 2014; 103(3):237–45.
Busse R. Disease management programs in germany’s statutory health insurance system. Health Aff. 2004; 23(3):56–67.
Laxy M, Stark R, Meisinger C, Kirchberger I, Heier M, von Scheidt W, Holle R. The effectiveness of german disease management programs (dmps) in patients with type 2 diabetes mellitus and coronary heart disease: results from an observational longitudinal study. Diabetol Metab Syndr. 2015; 7(1):1–11.
Bohley S, Trocchi P, Robra BP, Mau W, Stang A. The regional myocardial infarction registry of saxony-anhalt (rhesa) in germany - rational and study protocol. BMC Cardiovasc Disord. 2015; 15(1):45.
Böthig S. Who monica project: objectives and design. Int J Epidemiol. 1988; 18(3 Suppl 1):29–37.
Löwel H, Meisinger C, Heier M, Hörmann A. The population-based acute myocardial infarction (ami) registry of the monica/kora study region of augsburg. Gesundheitswesen. 2005; 67(Suppl 1):31–7.
Greiser KH, Kluttig A, Schumann B, Kors JA, Swenne CA, Kuss O, Werdan K, Haerting J. Cardiovascular disease, risk factors and heart rate variability in the elderly general population: design and objectives of the cardiovascular disease, living and ageing in halle (carla) study. BMC Cardiovasc Disord. 2005; 5(1):33.
Kluttig A, Trocchi P, Heinig A, Holzhausen HJ, Taege C, Hauptmann S, Boecker W, Decker T, Loening T, Schmidt-Pokrzywniak A, et al. Reliability and validity of needle biopsy evaluation of breast-abnormalities using the b-categorization–design and objectives of the diagnosis optimisation study (dios). BMC Cancer. 2007; 7(1):100.
Lamprecht J, Behrens J, Mau W, S M. Das intensivierte rehabilitationsnachsorgeprogramm (irena) der deutschen rentenversicherung bund - berufsbegleitende inanspruchnahme und veränderungen berufsbezogener parmeter. Rehabilitation (Stutg). 2011; 50(3):186–94.
Bellach BM. Leitlinien und empfehlungen zur sicherung von guter epidemiologischer praxis (gep) eine mitteilung der arbeitsgruppe epidemiologische methoden der deutschen arbeitsgemeinschaft epidemiologie (dae). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2000; 43(6):468–75.
Latza U, Hoffmann W, Terschüren C, Chang-Claude J, Kreuzer M, Schaffrath Rosario A, Kropp S, Stang A, Ahrens W, Lampert T. Erhebung, Quantifizierung und Analyse der Rauchexposition in Epidemiologischen Studien. Berlin: Robert-Koch-Inst; 2004.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24(1):67–74.
Tan X, Patel I, Chang J. Review of the four item morisky medication adherence scale (mmas-4) and eight item morisky medication adherence scale (mmas-8). Innov Pharm. 2014; 5(3):5.
van Reenen M, Oppe M. EQ-5D-3L User Guide: Basic Information on How to Use the EQ-5D-3L Instrument, version 5.1 edn. Rotterdam: EuroQol Research Foundation; 2015.
Yesavage JA, Brink T, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1983; 17(1):37–49.
Yesavage JA, Sheikh JI. 9/geriatric depression scale (gds) recent evidence and development of a shorter violence. Clin Gerontol. 1986; 5(1-2):165–73.
Jöckel KH, et al.Messung und quantifizierung soziodemographische merkmale in epidemiologischen studien. RKI-Schriften. 1998; 1:7–38.
We would like to thank Prof. Dr. Christa Meisinger, Dr. Inge Kirchberger (KORA), and Prof. Dr. Andreas Klement (IMEBI) for their support in developing the questionnaires. Furthermore, we would like to thank the study personnel Yves Froese, Lennart Pie, Patricia Stein, and Lena Katharina Wehle.
RHESA-CARE is fund by the Wilhelm Roux Program of the Faculty of Medicine of the Martin Luther University Halle-Wittenberg (FKZ 28/35).
Availability of data and materials
KH drafted the manuscript, co-ordinated the study, and helped to design the study. SB helped to design the study and helped to draft the manuscript. WM developed parts of the questionnaire and helped to draft the manuscript. ASP conducted the study and helped to draft the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
RHESA was approved by the Ethics Committee of the Medical Faculty of the Martin Luther University Halle-Wittenberg and by the State Data Protection and Privacy Commissioner of Saxony-Anhalt. As a part of RHESA, the ethics for the RHESA-CARE Study are included in those of the RHESA.
About this article
Cite this article
Hirsch, K., Bohley, S., Mau, W. et al. The RHESA-CARE study: an extended baseline survey of the regional myocardial infarction registry of Saxony-Anhalt (RHESA) design and objectives. BMC Cardiovasc Disord 16, 159 (2016) doi:10.1186/s12872-016-0336-x
- Myocardial infarction
- Cohort study